IL159698A0 - Novel anticonvulsant derivative salts - Google Patents

Novel anticonvulsant derivative salts

Info

Publication number
IL159698A0
IL159698A0 IL15969802A IL15969802A IL159698A0 IL 159698 A0 IL159698 A0 IL 159698A0 IL 15969802 A IL15969802 A IL 15969802A IL 15969802 A IL15969802 A IL 15969802A IL 159698 A0 IL159698 A0 IL 159698A0
Authority
IL
Israel
Prior art keywords
derivative salts
novel anticonvulsant
anticonvulsant derivative
novel
salts
Prior art date
Application number
IL15969802A
Other languages
English (en)
Original Assignee
Ortho Mcnell Pharmaceutical In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23174444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL159698(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Mcnell Pharmaceutical In filed Critical Ortho Mcnell Pharmaceutical In
Publication of IL159698A0 publication Critical patent/IL159698A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
IL15969802A 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts IL159698A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30396201P 2001-07-09 2001-07-09
PCT/US2002/021016 WO2003006467A1 (en) 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts

Publications (1)

Publication Number Publication Date
IL159698A0 true IL159698A0 (en) 2004-06-20

Family

ID=23174444

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15969802A IL159698A0 (en) 2001-07-09 2002-07-03 Novel anticonvulsant derivative salts
IL159698A IL159698A (en) 2001-07-09 2004-01-02 Salts of anticonvulsant derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159698A IL159698A (en) 2001-07-09 2004-01-02 Salts of anticonvulsant derivatives

Country Status (27)

Country Link
US (2) US7098188B2 (es)
EP (1) EP1414824B1 (es)
JP (1) JP2005502629A (es)
KR (1) KR20040013127A (es)
CN (1) CN1288159C (es)
AR (1) AR036137A1 (es)
AT (1) ATE361304T1 (es)
AU (1) AU2002346042B2 (es)
BR (1) BR0211063A (es)
CA (1) CA2452612A1 (es)
DE (1) DE60219922T2 (es)
DK (1) DK1414824T3 (es)
ES (1) ES2284884T3 (es)
HK (1) HK1064094A1 (es)
HR (1) HRP20040017A2 (es)
HU (1) HUP0401080A2 (es)
IL (2) IL159698A0 (es)
MX (1) MXPA04000232A (es)
NO (1) NO20040066L (es)
NZ (1) NZ530507A (es)
PL (1) PL367635A1 (es)
PT (1) PT1414824E (es)
RU (1) RU2320665C2 (es)
SI (1) SI21370A (es)
UA (1) UA78211C2 (es)
WO (1) WO2003006467A1 (es)
ZA (1) ZA200400970B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041650B2 (en) 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
CA2465952A1 (en) * 2001-11-06 2003-05-15 Ortho-Mcneil Pharmaceutical, Inc. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US6559293B1 (en) * 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
JP4906233B2 (ja) 2002-03-01 2012-03-28 ユニバーシティー オブ サウス フロリダ 少なくとも１種の有効薬剤成分を含有する多構成要素固相
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
MXPA05000232A (es) * 2002-06-21 2005-06-17 Transform Pharmaceuticals Inc Composiciones farmaceuticas con disolucion mejorada.
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7638291B2 (en) * 2004-10-25 2009-12-29 Seradyn, Inc. Immunoassays for topiramate
US20060088886A1 (en) * 2004-10-25 2006-04-27 Anlong Ouyang Topiramate analogs
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9489372B2 (en) * 2013-03-15 2016-11-08 Apple Inc. Web-based spell checker
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
TWI826531B (zh) 2018-09-21 2023-12-21 南韓商愛思開生物製藥股份有限公司 具有㗁二唑之化合物及包含該化合物之醫藥組合物
US20210169844A1 (en) 2019-12-10 2021-06-10 Tulex Pharmaceuticals Inc. Compositions and methods for treating epilepsy, seizures and other conditions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU651244B2 (en) * 1991-09-19 1994-07-14 Mcneilab, Inc. Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-D- fructopyranose and (1-methylcyclohexyl)methanol
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates
US5384327A (en) * 1992-12-22 1995-01-24 Mcneilab, Inc. Anticonvulsant sorbopyranose sulfamates
US5498629A (en) * 1993-12-23 1996-03-12 Ortho Pharmaceutical Corporation Anticonvulsant pseudofructopyranose sulfamates
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
US5952187A (en) * 1995-12-01 1999-09-14 Oxis International, Inc. Topiramate immunoassay
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
BR0008477A (pt) * 1999-02-24 2002-01-22 Univ Cincinnati Método para tratar um distúrbio de controle do impulso
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
US6559293B1 (en) 2002-02-15 2003-05-06 Transform Pharmaceuticals, Inc. Topiramate sodium trihydrate

Also Published As

Publication number Publication date
WO2003006467A1 (en) 2003-01-23
UA78211C2 (en) 2007-03-15
ATE361304T1 (de) 2007-05-15
ES2284884T3 (es) 2007-11-16
NO20040066L (no) 2004-03-01
NZ530507A (en) 2007-01-26
CA2452612A1 (en) 2003-01-23
IL159698A (en) 2009-09-22
CN1288159C (zh) 2006-12-06
US7098188B2 (en) 2006-08-29
AU2002346042B8 (en) 2003-01-29
DE60219922T2 (de) 2008-01-17
JP2005502629A (ja) 2005-01-27
HK1064094A1 (en) 2005-01-21
PL367635A1 (en) 2005-03-07
CN1551882A (zh) 2004-12-01
RU2320665C2 (ru) 2008-03-27
HRP20040017A2 (en) 2004-10-31
RU2004100274A (ru) 2005-06-20
PT1414824E (pt) 2007-06-27
BR0211063A (pt) 2004-07-20
AU2002346042B2 (en) 2007-10-18
DE60219922D1 (de) 2007-06-14
DK1414824T3 (da) 2007-07-16
HUP0401080A2 (hu) 2004-09-28
KR20040013127A (ko) 2004-02-11
SI21370A (sl) 2004-06-30
ZA200400970B (en) 2005-02-07
EP1414824B1 (en) 2007-05-02
MXPA04000232A (es) 2005-03-07
US20030069190A1 (en) 2003-04-10
AR036137A1 (es) 2004-08-11
US20060105966A1 (en) 2006-05-18
EP1414824A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
GB2371217B (en) Toothbrush
ZA200309522B (en) Substituted cyclohexane-1-4diamine derivatives
HK1067020A1 (en) Toothbrush
AU148689S (en) Toothbrush
AU146402S (en) Toothbrush
PL368816A1 (en) 3-substituted-4-pyrimidone derivatives
AU147485S (en) Toothbrush
AU150163S (en) Toothbrush
IL158388A0 (en) Novel arylheteroalkylamine derivatives
AU148697S (en) Toothbrush
AU148071S (en) Toothbrush
AU147487S (en) Toothbrush
HK1064094A1 (en) Novel anticonvulsant derivative salts
AU147486S (en) Toothbrush
AU149539S (en) Toothbrush
AU150162S (en) Toothbrush
HUP0303449A3 (en) Substituted benzofuran-2-carboxamides derivatives
IL169505A0 (en) Novel anticonvulsant derivatives salts
AU146620S (en) Toothbrush
GB0116347D0 (en) Toothbrush
EP1364954A4 (en) Dicarba closo DODECARBORANDERIVATE
GB0124428D0 (en) Toothbrush
AU147244S (en) Toothbrush
CA93334S (en) Toothbrush
CA92153S (en) Toothbrush